Onconetix, Inc. (ONCO)
2.80
+0.03
(+1.02%)
USD |
NASDAQ |
Dec 10, 16:00
2.90
+0.10
(+3.57%)
After-Hours: 20:00
Onconetix Cash from Investing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Veru, Inc. | 0.4741M |
| GT Biopharma, Inc. | 0.00 |
| NovaBridge Biosciences | -- |
| CEL-SCI Corp. | 0.00 |
| AIM ImmunoTech, Inc. | 0.296M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.178M |
| Cash from Financing (Quarterly) | 4.291M |
| Free Cash Flow | -7.909M |
| Free Cash Flow Per Share (Quarterly) | -2.261 |
| Free Cash Flow to Equity (Quarterly) | 5.409M |
| Free Cash Flow to Firm (Quarterly) | -2.878M |
| Free Cash Flow Yield | -485.9% |